Grants and Contributions:
Title:
Scoping new product lines
Agreement Number:
999871
Agreement Value:
$75,000.00
Agreement Date:
Jan 2, 2023 - Apr 30, 2023
Description:
Traferox has recently developed and commercialized the TorEx Lung Perfusion System. The technology developed and integrated in this system can be used in new clinical applications. This project will define these applications and lay the groundwork for future products.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Mississauga, Ontario, CA L5L 5Y7
Reference Number:
172-2022-2023-Q3-999871
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
717995286
Recipient Type:
For-profit organization
Recipient's Legal Name:
Traferox Technologies Inc
Federal Riding Name:
Mississauga--Erin Mills
Federal Riding Number:
35060
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110